Geode Capital Management, LLC Bridge Bio Pharma, Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 3,413,949 shares of BBIO stock, worth $90.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,413,949

Previous 3,290,409 3.75%

Holding current value

$90.8 Million

Previous $83.3 Million 4.29%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$23.91 - $31.3 $2.95 Million - $3.87 Million	123,540 Added 3.75%	3,413,949 $86.9 Million
Q2 2024 Aug 09, 2024	BUY	$23.0 - $31.04 $9.83 Million - $13.3 Million	427,564 Added 14.93%	3,290,409 $83.3 Million
Q1 2024 May 13, 2024	BUY	$27.35 - $40.45 $4.07 Million - $6.01 Million	148,677 Added 5.48%	2,862,845 $88.5 Million
Q4 2023 Feb 13, 2024	BUY	$24.02 - $43.89 $4.88 Million - $8.91 Million	202,988 Added 8.08%	2,714,168 $110 Million
Q3 2023 Nov 13, 2023	BUY	$16.89 - $35.01 $1.55 Million - $3.21 Million	91,810 Added 3.79%	2,511,180 $66.2 Million
Q2 2023 Aug 11, 2023	BUY	$13.29 - $18.01 $2.21 Million - $2.99 Million	166,212 Added 7.38%	2,419,370 $41.6 Million
Q1 2023 May 15, 2023	BUY	$7.17 - $18.55 $1.34 Million - $3.47 Million	187,251 Added 9.06%	2,253,158 $37.4 Million
Q4 2022 Feb 13, 2023	BUY	$6.74 - $11.52 $687,682 - $1.18 Million	102,030 Added 5.2%	2,065,907 $15.7 Million
Q3 2022 Nov 14, 2022	SELL	$7.94 - $12.36 $52,157 - $81,192	-6,569 Reduced 0.33%	1,963,877 $19.5 Million
Q2 2022 Aug 12, 2022	BUY	$5.21 - $12.14 $968,382 - $2.26 Million	185,870 Added 10.42%	1,970,446 $17.9 Million
Q1 2022 May 13, 2022	SELL	$7.34 - $17.16 $1.05 Million - $2.45 Million	-142,835 Reduced 7.41%	1,784,576 $18.1 Million
Q4 2021 Feb 11, 2022	SELL	$11.38 - $53.41 $223,890 - $1.05 Million	-19,674 Reduced 1.01%	1,927,411 $32.1 Million
Q3 2021 Nov 12, 2021	BUY	$46.87 - $64.24 $5.77 Million - $7.91 Million	123,147 Added 6.75%	1,947,085 $91.3 Million
Q2 2021 Aug 13, 2021	BUY	$46.47 - $63.93 $7.48 Million - $10.3 Million	160,981 Added 9.68%	1,823,938 $111 Million
Q1 2021 May 12, 2021	BUY	$55.47 - $72.35 $25.1 Million - $32.8 Million	453,236 Added 37.47%	1,662,957 $102 Million
Q4 2020 Feb 12, 2021	BUY	$38.38 - $71.11 $1.96 Million - $3.63 Million	51,066 Added 4.41%	1,209,721 $86 Million
Q3 2020 Nov 13, 2020	BUY	$27.2 - $42.19 $11.6 Million - $18 Million	425,720 Added 58.08%	1,158,655 $43.5 Million
Q2 2020 Aug 13, 2020	BUY	$22.22 - $35.69 $226,599 - $363,966	10,198 Added 1.41%	732,935 $23.9 Million
Q1 2020 May 14, 2020	BUY	$16.11 - $36.23 $6.05 Million - $13.6 Million	375,359 Added 108.05%	722,737 $21 Million
Q4 2019 Feb 13, 2020	BUY	$17.96 - $46.63 $214,262 - $556,295	11,930 Added 3.56%	347,378 $12.2 Million
Q3 2019 Nov 12, 2019	BUY	$20.13 - $32.38 $6.75 Million - $10.9 Million	335,448 New	335,448 $7.2 Million

Others Institutions Holding BBIO

# of Institutions

291

Shares Held

171M

Call Options Held

10.4M

Put Options Held

2.37M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.94B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Bridge Bio Pharma, Inc. Transaction History